Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul;10(7):2340-2342.
doi: 10.21037/gs-21-379.

Letter to the editor: the nonnegligible effect of neoadjuvant therapy for patients with borderline resectable pancreatic ductal adenocarcinoma

Li Wang  1 , Xin Zhang  2 , Yanrong Lu  1 , Bole Tian  1
Affiliations
Comment

Letter to the editor: the nonnegligible effect of neoadjuvant therapy for patients with borderline resectable pancreatic ductal adenocarcinoma

Li Wang et al. Gland Surg. 2021 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://dx.doi.org/10.21037/gs-21-379). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Forest plots of the effects of NAT on clinical pancreatic fistula for PDAC patients. NAT, neoadjuvant therapy; PDAC, pancreatic ductal adenocarcinoma; OR, odds ratio; CI, confidence interval.
See this image and copyright information in PMC

Comment on

References

    1. Beger HG, Mayer B. Early postoperative and late metabolic morbidity after pancreatic resections: An old and new challenge for surgeons - A review. Am J Surg 2018;216:131-4. 10.1016/j.amjsurg.2018.02.014 - DOI - PubMed
    1. Wang J, Lyu SC, Zhou L, et al. Prognostic analysis of pancreatic carcinoma with portal system invasion following curative resection. Gland Surg 2021;10:35-49. 10.21037/gs-20-495 - DOI - PMC - PubMed
    1. Araujo RL, Gaujoux S, Huguet F, et al. Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-matched analysis. HPB (Oxford) 2013;15:574-80. 10.1111/hpb.12033 - DOI - PMC - PubMed
    1. Dahdaleh FS, Naffouje SA, Hanna MH, et al. Impact of Neoadjuvant Systemic Therapy on Pancreatic Fistula Rates Following Pancreatectomy: a Population-Based Propensity-Matched Analysis. J Gastrointest Surg 2021;25:747-56. 10.1007/s11605-020-04581-y - DOI - PubMed
    1. Hank T, Sandini M, Ferrone CR, et al. Association Between Pancreatic Fistula and Long-term Survival in the Era of Neoadjuvant Chemotherapy. JAMA Surg 2019;154:943-51. 10.1001/jamasurg.2019.2272 - DOI - PMC - PubMed